2.70TWD
162.91 MTWD
1.54 BTWD
26.46 M
About DV BIOMED CO LTD
Sector
Industry
CEO
Chia Chu Tsai
Website
Headquarters
Taipei
Founded
2011
FIGI
BBG00B59KTG7
DV Biomed Co., Ltd. engages in the research and development of stem cells, genomics, anti-cancer drug, and proteomics. It offers stem cell service, slimming beauty service, and skin care products. The company was founded by Chia Chu Tsai on June 21, 2011 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6539 is 44.50 TWD — it has decreased by 2.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange DV BIOMED CO LTD stocks are traded under the ticker 6539.
6539 stock is 2.25% volatile and has beta coefficient of 0.22. Check out the list of the most volatile stocks — is DV BIOMED CO LTD there?
Yes, you can track DV BIOMED CO LTD financials in yearly and quarterly reports right on TradingView.
6539 stock has risen by 1.02% compared to the previous week, the month change is a 3.49% rise, over the last year DV BIOMED CO LTD has showed a 31.54% decrease.
6539 net income for the last quarter is 37.63 M TWD, while the quarter before that showed 125.28 M TWD of net income which accounts for −69.96% change. Track more DV BIOMED CO LTD financial stats to get the full picture.
DV BIOMED CO LTD dividend yield was 6.10% in 2023, and payout ratio reached 110.11%. The year before the numbers were 9.55% and 112.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6539 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DV BIOMED CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DV BIOMED CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DV BIOMED CO LTD stock shows the strong sell signal. See more of DV BIOMED CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DV BIOMED CO LTD EBITDA is 367.58 M TWD, and current EBITDA margin is 23.89%. See more stats in DV BIOMED CO LTD financial statements.